Striving to Extend Healthspan! Crowdfunding Campaign Launched for 'Reduced Coenzyme Q10 x Assist NMN' Supplement
NQ Score
82/100
N1 Content Completeness
9
AI Summary (NQ-processed)
First Innovation has launched a crowdfunding support project for Furofushi Research Institute's new supplement, 'Reduced Coenzyme Q10 x Assist NMN', aimed at helping busy professionals maintain their condition.
AI Analysis
Frequently Asked Questions
- Q: What are the benefits of the crowdfunding campaign?
- A: Supporters can purchase at a special price of up to 75% off, with options for both individuals and companies to support the project.
- Q: What is the origin of this product's development?
- A: It was inspired by CEO Koji Hayashi's experience as a secretary to the founder of H.I.S., aiming to solve the heavy burden on executives' health.
- Q: Who is this product for?
- A: It is intended for busy executives, professionals, and active individuals who need to maintain their performance and condition.